ArticleKidney international reports2024

The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy.

Dana Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.